Scholarlink

<p>Ovarian cancer (OC) is a leading cause of gynecologic cancer mortality, poses significant diagnostic challenges due to its inter- and intra-tumoral heterogeneity. Conventional qualitative imaging often fails to capture such complexity, whereas radiomics is specifically designed to address it. By integrating imaging features with clinical, genomic, or proteomic data, these approaches reveal sub-visual heterogeneity and enhance diagnostic accuracy. Ultrasound-based radiomics and radiogenomics further extend its clinical utility. Virtual biopsy techniques, such as radiomic habitat maps fused with ultrasound, enable real-time, multi-site sampling to predict prognosis, peritoneal metastasis, and recurrence. This review synthesizes recent advancements in ultrasound-based radiomics and radiogenomics for OC, focusing on their clinical utility in improving diagnostic accuracy, prognostic stratification, and personalized therapeutic strategies. Despite progress, challenges such as insufficient standardization and limited model interpretability persist. Future efforts should prioritize AI-augmented analytical pipelines, multicenter prospective validation, and biomarker discovery to bridge imaging phenotypes with precision oncology framework in OC management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Radiomics and radiogenomics in ovarian cancer: a review with a focus on ultrasound applications

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月11日

查看全文
  • Yiyang Huang,
  • Wangrui Peng,
  • Huai Yang,
  • Zichao Liu,
  • Tingyu Zhang,
  • Linyuan Jin,
  • Wen He,
  • Meng Du,
  • Zhiyi Chen

摘要

Ovarian cancer (OC) is a leading cause of gynecologic cancer mortality, poses significant diagnostic challenges due to its inter- and intra-tumoral heterogeneity. Conventional qualitative imaging often fails to capture such complexity, whereas radiomics is specifically designed to address it. By integrating imaging features with clinical, genomic, or proteomic data, these approaches reveal sub-visual heterogeneity and enhance diagnostic accuracy. Ultrasound-based radiomics and radiogenomics further extend its clinical utility. Virtual biopsy techniques, such as radiomic habitat maps fused with ultrasound, enable real-time, multi-site sampling to predict prognosis, peritoneal metastasis, and recurrence. This review synthesizes recent advancements in ultrasound-based radiomics and radiogenomics for OC, focusing on their clinical utility in improving diagnostic accuracy, prognostic stratification, and personalized therapeutic strategies. Despite progress, challenges such as insufficient standardization and limited model interpretability persist. Future efforts should prioritize AI-augmented analytical pipelines, multicenter prospective validation, and biomarker discovery to bridge imaging phenotypes with precision oncology framework in OC management.